Metabolomic Impacts of Branched-chain Amino Acid Supplementation During Endurance Exercise
1 other identifier
interventional
10
1 country
1
Brief Summary
The overall goal of this investigation was to determine the impact of branch-chained amino acids (BCAAs) supplementation on serotonin and associated metabolites during endurance exercise on healthy individuals. Specifically, despite the strong theoretical basis for supplementation of BCAAs to attenuate serotonin production and fatigue during exercise, most human clinical trials have failed to demonstrate these benefits. To shed light on this discrepancy, the purpose of this study was to measure the impact of BCAA supplementation on serotonin and associated metabolites during exercise. To achieve this purpose, investigators determined the effects of the consumption of a BCAA beverage on endurance exercise performance and serum metabolites. The supplementation protocol consisted of two trials in which each participant consumed 8 grams of BCAA supplement in a beverage or a placebo in randomized order. It was hypothesized that post-exercise metabolites would differ between BCAA and placebo conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
Started Oct 2019
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 23, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 23, 2021
CompletedFirst Submitted
Initial submission to the registry
July 9, 2021
CompletedFirst Posted
Study publicly available on registry
July 20, 2021
CompletedMay 3, 2023
July 1, 2021
1.4 years
July 9, 2021
May 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Serotonin
Serum serotonin concentration
60 minutes
Untargeted metabolomics
Liquid chromatography mass spectrometry (LCMS) analysis of serum metabolites
60 minutes
Secondary Outcomes (1)
Rating of perceived exertion Borg Scale
60 minutes
Study Arms (2)
Branched chain amino acid supplementation
EXPERIMENTALConsumption of 8 ounces of water with addition of 2.5 g of leucine, 1.25 g of isoleucine, and 1.25 g of valine immediately prior to and again 30 minutes into a 60 minute treadmill run at 65% of VO2max.
Placebo
PLACEBO COMPARATORConsumption of 8 ounces of a flavor matched beverage sweetened with a sucralose-based drink mix immediately prior to and again 30 minutes into a 60 minute treadmill run at 65% of VO2max.
Interventions
Supplementation with 8 g Nutrex Research Amino Acid Drive BCAA in 8 ounces of water once each immediately pre-exercise and after 30 minutes of exercise
Supplementation with 2.0 milliliters of a sucralose-based drink mix with 8 ounces of water once each immediately pre-exercise and after 30 minutes of exercise
Eligibility Criteria
You may qualify if:
- Participate in at least 5 hours of cardiovascular activity per week
You may not qualify if:
- Any underlying injury
- The consumption of any selective serotonin re-uptake inhibitor (SSRI) medication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Montana State Universitylead
- M.J. Murdoch Charitable Trustcollaborator
- Kreighbaum Endowmentcollaborator
Study Sites (1)
Montana State University
Bozeman, Montana, 59717, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary P Miles, PhD
Montana State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Double-blind
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 9, 2021
First Posted
July 20, 2021
Study Start
October 1, 2019
Primary Completion
February 23, 2021
Study Completion
February 23, 2021
Last Updated
May 3, 2023
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share